119 related articles for article (PubMed ID: 17275100)
21. Pyrexia, anorexia, adipsia, and depressed motor activity in rats during systemic inflammation induced by the Toll-like receptors-2 and -6 agonists MALP-2 and FSL-1.
Hübschle T; Mütze J; Mühlradt PF; Korte S; Gerstberger R; Roth J
Am J Physiol Regul Integr Comp Physiol; 2006 Jan; 290(1):R180-7. PubMed ID: 16154916
[TBL] [Abstract][Full Text] [Related]
22. Vanadium-induced chemokine mRNA expression and pulmonary inflammation.
Pierce LM; Alessandrini F; Godleski JJ; Paulauskis JD
Toxicol Appl Pharmacol; 1996 May; 138(1):1-11. PubMed ID: 8658498
[TBL] [Abstract][Full Text] [Related]
23. Macrophage activating lipopeptide 2 is effective in mycobacterial lung infection.
Tschernig T; Pabst R
Ann Anat; 2021 Jan; 233():151605. PubMed ID: 32949720
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.
Reppe K; Radünzel P; Dietert K; Tschernig T; Wolff T; Hammerschmidt S; Gruber AD; Suttorp N; Witzenrath M
Infect Immun; 2015 Dec; 83(12):4617-29. PubMed ID: 26371127
[TBL] [Abstract][Full Text] [Related]
25. Fever induction by systemic stimulation with macrophage-activating lipopeptide-2 depends upon TLR2 but not CD36.
Welsch J; Hübschle T; Murgott J; Kirschning C; Rummel C; Gerstberger R; Roth J
Innate Immun; 2012 Jun; 18(3):541-59. PubMed ID: 22042912
[TBL] [Abstract][Full Text] [Related]
26. NADPH oxidase NOX2 mediates TLR2/6-dependent release of GM-CSF from endothelial cells.
Schuett J; Schuett H; Oberoi R; Koch AK; Pretzer S; Luchtefeld M; Schieffer B; Grote K
FASEB J; 2017 Jun; 31(6):2612-2624. PubMed ID: 28274989
[TBL] [Abstract][Full Text] [Related]
27. Macrophage-activating lipopeptide-2 induces cyclooxygenase-2 and prostaglandin E(2) via toll-like receptor 2 in human placental trophoblast cells.
Mitsunari M; Yoshida S; Shoji T; Tsukihara S; Iwabe T; Harada T; Terakawa N
J Reprod Immunol; 2006 Dec; 72(1-2):46-59. PubMed ID: 16600383
[TBL] [Abstract][Full Text] [Related]
28. Lymphocyte subsets in distinct lung compartments show a different ability to produce interferon-gamma (IFN-gamma) during a pulmonary immune response.
Klemm A; Tschernig T; Krug N; Pabst R
Clin Exp Immunol; 1998 Aug; 113(2):252-7. PubMed ID: 9717975
[TBL] [Abstract][Full Text] [Related]
29. MALP-2, a Mycoplasma lipopeptide with classical endotoxic properties: end of an era of LPS monopoly?
Galanos C; Gumenscheimer M; Mühlradt P; Jirillo E; Freudenberg M
J Endotoxin Res; 2000; 6(6):471-6. PubMed ID: 11521073
[TBL] [Abstract][Full Text] [Related]
30. Toll-like receptor 2/6 agonist macrophage-activating lipopeptide-2 promotes reendothelialization and inhibits neointima formation after vascular injury.
Grote K; Sonnenschein K; Kapopara PR; Hillmer A; Grothusen C; Salguero G; Kotlarz D; Schuett H; Bavendiek U; Schieffer B
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2097-104. PubMed ID: 23868938
[TBL] [Abstract][Full Text] [Related]
31. [Deep lung--cellular reaction to HIV].
Tavares Marques MA; Alves V; Duque V; Botelho MF
Rev Port Pneumol; 2007; 13(2):175-212. PubMed ID: 17492233
[TBL] [Abstract][Full Text] [Related]
32. Cyptoporus polysaccharide prevents lipopolysaccharide-induced acute lung injury associated with down-regulating Toll-like receptor 2 expression.
Yao HY; Zhang LH; Shen J; Shen HJ; Jia YL; Yan XF; Xie QM
J Ethnopharmacol; 2011 Oct; 137(3):1267-74. PubMed ID: 21875662
[TBL] [Abstract][Full Text] [Related]
33. Toll-like receptor 2/6 stimulation promotes angiogenesis via GM-CSF as a potential strategy for immune defense and tissue regeneration.
Grote K; Schuett H; Salguero G; Grothusen C; Jagielska J; Drexler H; Mühlradt PF; Schieffer B
Blood; 2010 Mar; 115(12):2543-52. PubMed ID: 20056792
[TBL] [Abstract][Full Text] [Related]
34. Direct stimulatory effects of the TLR2/6 ligand bacterial lipopeptide MALP-2 on neutrophil granulocytes.
Wilde I; Lotz S; Engelmann D; Starke A; van Zandbergen G; Solbach W; Laskay T
Med Microbiol Immunol; 2007 Jun; 196(2):61-71. PubMed ID: 17006695
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary toxicity of polyvinyl chloride particles after repeated intratracheal instillations in rats. Elevated CD4/CD8 lymphocyte ratio in bronchoalveolar lavage.
Xu H; Vanhooren HM; Verbeken E; Yu L; Lin Y; Nemery B; Hoet PH
Toxicol Appl Pharmacol; 2004 Jan; 194(2):122-31. PubMed ID: 14736493
[TBL] [Abstract][Full Text] [Related]
36. Innate immunity alterations in idiopathic interstitial pneumonias and rheumatoid arthritis-associated interstitial lung diseases.
Papanikolaou IC; Boki KA; Giamarellos-Bourboulis EJ; Kotsaki A; Kagouridis K; Karagiannidis N; Polychronopoulos VS
Immunol Lett; 2015 Feb; 163(2):179-86. PubMed ID: 25540922
[TBL] [Abstract][Full Text] [Related]
37. Murine TLR4 is implicated in cigarette smoke-induced pulmonary inflammation.
Maes T; Bracke KR; Vermaelen KY; Demedts IK; Joos GF; Pauwels RA; Brusselle GG
Int Arch Allergy Immunol; 2006; 141(4):354-68. PubMed ID: 16940747
[TBL] [Abstract][Full Text] [Related]
38. Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvant.
Borsutzky S; Fiorelli V; Ebensen T; Tripiciano A; Rharbaoui F; Scoglio A; Link C; Nappi F; Morr M; Buttó S; Cafaro A; Mühlradt PF; Ensoli B; Guzmán CA
Eur J Immunol; 2003 Jun; 33(6):1548-56. PubMed ID: 12778472
[TBL] [Abstract][Full Text] [Related]
39. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
Okuma T; Terasaki Y; Kaikita K; Kobayashi H; Kuziel WA; Kawasuji M; Takeya M
J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737
[TBL] [Abstract][Full Text] [Related]
40. The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells.
Borsutzky S; Kretschmer K; Becker PD; Mühlradt PF; Kirschning CJ; Weiss S; Guzmán CA
J Immunol; 2005 May; 174(10):6308-13. PubMed ID: 15879130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
